2 news items
SAB Biotherapeutics to Present at INNODIA Annual Meeting
SABS
8 Apr 24
innovation in T1D, INNODIA provides full support to SMEs, biotechs, and other entities that might otherwise not invest in T1D R&D due
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
SABS
29 Mar 24
. Hosted 2023 R&D Day virtual and in-person events, affirming SAB's strategic focus in the autoimmunity space with SAB-142, a disease-modifying fully
- Prev
- 1
- Next